Naomi Shuwari (Graduated School of Pharmaceutical Sciences, Osaka University)
Session information
Oral Session
[OR3] Oral Session Ⅲ Cancer②
Thu. Jul 14, 2022 3:30 PM - 4:42 PM Room 3 (3F 304)
Chair persons : Shuji Kubo(Laboratory of Molecular and Genetic Therapeutics, Institute for Advanced Medical Sciences, Hyogo College of Medicine),Hajime Kurosaki(Division of Molecular Medicine, Department of Genomic Medicine and Regenerative Therapeutics, School of Medicine, Tottori University Faculty of Medicine)
Ryoji Imoto (Department of Neurological Surgery, Okayama University Graduate School)
Ryohei Shoji (Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan)
Mohamed Abdelmoneim (Cancer Immune Therapy Research Center, Graduate School of Medicine, Nagoya University,Nagoya, Japan / Department of Surgery II, Graduate School of Medicine, Nagoya University,Nagoya, Japan / Department of Microbiology, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt)
Kei Hiraoka (Department of Gastroenterological Surgery II, Hokkaido University Graduate School of Medicine /Department of Clinical Research, National Hospital Organization (NHO) Hakodate National Hospital)
Hiroki Niwa (Department of Gastroenterological Surgery II, Hokkaido University Graduate School of Medicine)